vs
Midland States Bancorp, Inc.（MSBI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Midland States Bancorp, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$79.5M vs $75.5M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -6.4%）
雷德尼爾銀行公司是總部位於西雅圖的雷德尼爾國家銀行的母公司，該銀行是華盛頓州的本土銀行，在全州設有多家網點。其發展歷史可追溯至1889年理查德·霍利約克創辦的通商國家銀行，1974年正式更名為雷德尼爾國家銀行，此後陸續收購機構，將業務拓展至阿拉斯加與俄勒岡地區。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MSBI vs PBYI — 直观对比
营收规模更大
MSBI
是对方的1.1倍
$75.5M
两年增速更快
PBYI
近两年复合增速
-6.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.5M | $75.5M |
| 净利润 | $18.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 23.2% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 739.3% | — |
| 每股收益（稀释后） | $0.74 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MSBIPBYI
| Q1 26 | $79.5M | — | ||
| Q4 25 | $85.6M | $75.5M | ||
| Q3 25 | $81.1M | $54.5M | ||
| Q2 25 | $82.2M | $52.4M | ||
| Q1 25 | $76.1M | $46.0M | ||
| Q4 24 | $93.9M | $59.1M | ||
| Q3 24 | $92.7M | $80.5M | ||
| Q2 24 | $90.9M | $47.1M |
净利润MSBIPBYI
| Q1 26 | $18.5M | — | ||
| Q4 25 | $-2.9M | — | ||
| Q3 25 | $7.6M | $8.8M | ||
| Q2 25 | $12.0M | $5.9M | ||
| Q1 25 | $-141.0M | $3.0M | ||
| Q4 24 | $-30.8M | — | ||
| Q3 24 | $20.4M | $20.3M | ||
| Q2 24 | $25.7M | $-4.5M |
毛利率MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | -5.5% | 22.7% | ||
| Q3 25 | 13.9% | 17.6% | ||
| Q2 25 | 18.1% | 12.7% | ||
| Q1 25 | -181.2% | 8.7% | ||
| Q4 24 | -66.5% | 22.6% | ||
| Q3 24 | 26.9% | 27.4% | ||
| Q2 24 | 35.0% | -4.6% |
净利率MSBIPBYI
| Q1 26 | 23.2% | — | ||
| Q4 25 | -4.9% | — | ||
| Q3 25 | 9.3% | 16.2% | ||
| Q2 25 | 14.6% | 11.2% | ||
| Q1 25 | -185.4% | 6.5% | ||
| Q4 24 | -52.5% | — | ||
| Q3 24 | 22.1% | 25.2% | ||
| Q2 24 | 28.3% | -9.6% |
每股收益（稀释后）MSBIPBYI
| Q1 26 | $0.74 | — | ||
| Q4 25 | $-0.22 | $0.26 | ||
| Q3 25 | $0.24 | $0.17 | ||
| Q2 25 | $0.44 | $0.12 | ||
| Q1 25 | $-6.58 | $0.06 | ||
| Q4 24 | $-1.49 | $0.40 | ||
| Q3 24 | $0.83 | $0.41 | ||
| Q2 24 | $1.06 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.4M | $97.5M |
| 总债务越低越好 | $33.2M | $22.7M |
| 股东权益账面价值 | $569.5M | $130.3M |
| 总资产 | $6.5B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.06× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MSBIPBYI
| Q1 26 | $89.4M | — | ||
| Q4 25 | $127.8M | $97.5M | ||
| Q3 25 | $166.1M | $94.4M | ||
| Q2 25 | $176.6M | $96.0M | ||
| Q1 25 | $102.0M | $93.2M | ||
| Q4 24 | $114.8M | $101.0M | ||
| Q3 24 | $121.9M | $96.7M | ||
| Q2 24 | $124.6M | $96.8M |
总债务MSBIPBYI
| Q1 26 | $33.2M | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益MSBIPBYI
| Q1 26 | $569.5M | — | ||
| Q4 25 | $565.5M | $130.3M | ||
| Q3 25 | $584.0M | $115.3M | ||
| Q2 25 | $573.7M | $104.7M | ||
| Q1 25 | $571.4M | $97.1M | ||
| Q4 24 | $710.8M | $92.1M | ||
| Q3 24 | $771.2M | $71.1M | ||
| Q2 24 | $736.8M | $48.5M |
总资产MSBIPBYI
| Q1 26 | $6.5B | — | ||
| Q4 25 | $6.5B | $216.3M | ||
| Q3 25 | $6.9B | $202.9M | ||
| Q2 25 | $7.1B | $194.9M | ||
| Q1 25 | $7.3B | $196.2M | ||
| Q4 24 | $7.5B | $213.3M | ||
| Q3 24 | $7.7B | $220.7M | ||
| Q2 24 | $7.7B | $205.0M |
负债/权益比MSBIPBYI
| Q1 26 | 0.06× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | $125.7M | $14.4M | ||
| Q3 25 | $80.0M | $9.7M | ||
| Q2 25 | $28.1M | $14.1M | ||
| Q1 25 | $24.7M | $3.6M | ||
| Q4 24 | $176.5M | $15.6M | ||
| Q3 24 | $46.5M | $11.0M | ||
| Q2 24 | $31.4M | $1.0M |
自由现金流MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | $120.3M | $14.4M | ||
| Q3 25 | $78.6M | $9.7M | ||
| Q2 25 | $26.7M | $14.1M | ||
| Q1 25 | $22.9M | $3.6M | ||
| Q4 24 | $169.6M | $15.6M | ||
| Q3 24 | $44.4M | $11.0M | ||
| Q2 24 | $29.9M | $1.0M |
自由现金流率MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | 140.6% | 19.1% | ||
| Q3 25 | 96.9% | 17.7% | ||
| Q2 25 | 32.4% | 26.8% | ||
| Q1 25 | 30.1% | 7.7% | ||
| Q4 24 | 180.6% | 26.4% | ||
| Q3 24 | 47.9% | 13.7% | ||
| Q2 24 | 32.9% | 2.1% |
资本支出强度MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | 6.2% | 0.0% | ||
| Q3 25 | 1.7% | 0.0% | ||
| Q2 25 | 1.7% | 0.0% | ||
| Q1 25 | 2.4% | 0.1% | ||
| Q4 24 | 7.3% | 0.0% | ||
| Q3 24 | 2.3% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% |
现金转化率MSBIPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 10.58× | 1.10× | ||
| Q2 25 | 2.33× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.28× | 0.54× | ||
| Q2 24 | 1.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MSBI
| Net Interest Income | $57.4M | 72% |
| Noninterest Income | $22.1M | 28% |
PBYI
暂无分部数据
